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ENUMERARION OF T-CELLS IN PERIPHERAL
BLOOD AS WELL AS IN JOINT FLUID FROM
PATIENTS WITH RHEUMATOID ARTHRITIS
(RA) AND THE EFFECT OF CYCLOPHOSPHA-
MIDE
by Masaaki TOKIOKA M. D. and Kiyoshi TAKA-
SUGI M.D., D. Med. Sci. Institute jor Thermal
sPring Research & Okayama University Hospital
Misasa Branch
Abstract Gradient centrifugation was quite
useful in obtaining "mononuclear" cell fractions
from synovial fluids derived from patients with
rheumatoid arthritis. The ratio of lymphocytes
to monocytoid cells was similar to that seen in
peripheral blood. Prior treatment of the fluid
with hyaluronidase was found to be necessary to
obtain a satisfactory yield of the cells.
Sheep erythrocyte rosette-forming lymphocytes
(T-cells) were studied in 18 paired samples of
synovial fluid and blood in RA and 15 control
blood samples from normal persons were also
examined. In the paired synovial fluid and
blood samples from the RA patients, the mean
percentages of the T-cells were 56.6 and 47.1
respectively and the difference was statistically
significant (0.01<p<0.05). There was no sig-
nificant difference between T-cell percentages in
rheumatoid and control peripheral blood.
In two RA patients receiving cyclophosphamide
over an average period of 20 weeks, sequential
studies of T-cells were performed on both the
blood and synovial fluid. By the tenth week of
treatment, they were markedly reduced in both
synovial fluid and peripheral blood. By the 12th
to the 15th week, however, at a time when the
cumulative dose of cyclophosphamide was 5,000
mg, a rebound increase in T-cells was observed
in the synovial effusion. The numbers of the
T-cells in the blood concomitantly showed only a
minimal rebound.
